Otri-allergy Nasal Spray

Go To

Long-lasting relief
Blocks allergic reactions
Well tolderated profile
Proven allergy relief
Product details

Provides 24-hour relief of allergy symptoms¹

Nasal congestion
Runny nose
Sneezing
Itchy nose
Itchy eyes
Watery eyes

Blocks 6 key inflammatory mediators^*13-16

Otri-allergy Nasal Allergy works to help block allergic reactions, in order to relieve allergy symptoms through interference with more than 6 key inflammatory substances, including histamine, prostaglandins, cytokines, tryptases, chemokines and leukotrienes.^*13-16

*Mechanism vs most allergy pills. Otri-Allergy acts on multiple inflammatory mediators (histamine, prostaglandins, cytokines, tryptases, chemokines, and leukotrienes). The exact number and precise mechanism are unknown.¹

Very reliable profile with few contraindications^9,17,18

Otri-allergy Relief is NOT associated with:

Higher blood pressure, and is not contraindicated in patients with hypertension, heart disease, diabetes, liver disease, or kidney disease^8,9,17-20
Anticholinergic side effects commonly associated with some other allergy medications, such as drowsiness, dry mouth, nervousness, dizziness, or sleeplessness^8,9,17-24

Otri-allergy Nasal Spray: Proven 24‐hour Allergy Symptom Relief¹

Otri-allergy Nasal Spray

For patients who are looking for 24-hour relief of nasal and ocular symptoms of allergy.^1-12

Ingredients

Active Ingredient: 50 mcg Fluticasone Propionate (glucocorticoid) (0.05% w/w)

Other ingredients: Dextrose (anhydrous), Microcrystalline cellulose & Sodium carboxymethylcellulose, Phenylethyl alcohol, Benzalkonium chloride, Polysorbate 80, Dilute hydrochloric acid and Purified water.
Directions

Please read the patient information leaflet for full details
Warnings & Precautions

Please read the patient information leaflet for full details

Otri-allergy Nasal Spray Product Detail

The Otrivin range

Find out how the Otrivin range can help your patients.

Find out more

Register Now

Join the Community

Click here to register

Patient care resources

Download resources for your patients.

Find out more

References

Children’s FLONASE® Allergy Relief Label.
Haye R et al. Rhinology 1993; 31:169–174.
Bernstein DI et al. Clin Exp Allergy 2004; 34:952–957.
DeWester J et al. Allergy asthma Proc 2003; 24:331–337.
Nathan RA et al. Ann Allergy 1991; 67:332–338.
Banov CH et al. Ann Allergy 1994; 73:240–246.
Dykewicz MS et al. Ann Allergy Asthma Immunol 2003; 91:44–48.
Scadding GK et al. Clin Exp Allergy 1995; 25:737–743.
van As A et al. J Allergy Clin Immunol 1993; 91:1146–1154.
Data on file, GlaxoSmithKline. GSK: Result Summary for Study FNM40184. https://www.gsk-studyregister.com/en/trial-details/?id=FNM40184. 12-19-2005.
Ratner PH et al. Allergy asthma Proc 2002; 23:259–263.
Greiner AN et al. Lancet 2011; 378:2112–2122.
Derendorf H et al. Allergy 2008; 63:1292–1300.
Gelfand EW. J Allergy Clin Immunol 2004; 114:S135-138.
White MV et al. J Allergy Clin Immunol 1992; 90:699–704.
Bachert C et al. Allergy 1999; 54:116–123.
Greiner AN et al. Proc Am Thorac Soc 2011; 8:121–131.
Bousquet J et al. Allergy 2008; 63:8–160.
Storms W et al. Curr Med Res Opin 2007; 23:2135–2146.
Craig TJ et al. J Allergy Clin Immunol 1998; 101:633–637.
Sardana N et al. Asian Pacific J allergy Immunol 2011; 29:297–306.
MedlinePlus. Clemastine. http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682542.html. (Accessed January 2020).
MedlinePlus. Diphenhydramine. http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682539.html. (Accessed January 2020).
MedlinePlus. Chlorpheniramine. http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682543.html. (Accessed January 2020).

This site is intended for KSA healthcare professionals only.

For Full product information please refer to product pack & leaflet prior use. For reporting any Adverse Events or Side Effects for any of Haleon products, Please contact us on mystory.sa@haleon.com | Adverse Events hotline no.: +966 535533647

© 2025 Haleon group of companies or its licensor. All rights reserved.Trade marks are owned by or licensed to the Haleon group of companies.This website is operated by Haleon group of companies, 7864 Al Madinah Al Munawarah Road, As Salamah Dist, Jeddah 23525-3889

Item code: PM-SA-OTRI-23-00006

Preparation Date: 12 Oct 2023

Otri-allergy Nasal Spray

Provides 24-hour relief of allergy symptoms1

Blocks 6 key inflammatory mediators*13-16

Very reliable profile with few contraindications9,17,18

Otri-allergy Nasal Spray: Proven 24‐hour Allergy Symptom Relief1

Otri-allergy Nasal Spray

Otri-allergy Nasal Spray Product Detail

The Otrivin range

Register Now

Patient care resources

References

Provides 24-hour relief of allergy symptoms¹

Blocks 6 key inflammatory mediators^*13-16

Very reliable profile with few contraindications^9,17,18

Otri-allergy Nasal Spray: Proven 24‐hour Allergy Symptom Relief¹